Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation
- 15 August 1998
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 82 (4) , 433-437
- https://doi.org/10.1016/s0002-9149(98)00357-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1996
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancerThe Lancet, 1994
- Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1992
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJournal of the American College of Cardiology, 1991
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial FibrillationNew England Journal of Medicine, 1990
- Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous CathetersAnnals of Internal Medicine, 1990
- Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.BMJ, 1987
- Cardiogenic Brain EmbolismArchives of Neurology, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958